Investor Overview

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines.

Stock
Quote

Webcasts

06/09/2022
at 11:30 AM EDT
03/09/2022
at 11:10 AM PST
02/15/2022
at 3:00 PM PST

Financial Information

Document Date Description Form View

Form of prospectus disclosing information facts events covered in both forms 424B1 424B3

424B4 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425 View HTML

Contact
IR

Send us an investor-related question using the form below.